Safety of once- or twice-daily dosing of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with nonvalvular atrial fibrillation: A NOAC-TR study. Biomol Biomed. 2018;18(2):185-190. doi:10.17305/bjbms.2017.2279